Last month we announced that healthcare workers had been invited to take part in a WHO–endorsed research trial to investigate whether a BCG vaccine can help reduce the impact of COVID-19.
The trial has now been amended and is reopening for enrolment. The requirement of participants having had ‘no previous influenza vaccine’ has now been removed.
Traditionally used to prevent tuberculosis, the Bacille Calmette-Guérin (BCG) or a placebo vaccine will be given to participants.
Staff can now participate any time after 72 hours of receiving their flu immunisation.
A collaboration between the Murdoch Children’s Research Institute (MCRI) in Melbourne and Monash Health, the BRACE study invites Healthcare workers across Monash Health to participate in the randomised trial.
For further information, visit the MCRI website. Staff can register on the BRACE trial website coordinated by MCRI: www.mcri.edu.au/BRACE
Approved by Tony Korman, Director, Monash Infectious Diseases and Director, Microbiology, Monash Pathology
28 May 2020
